Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.
Watanabe R, Shirai T, Namkoong H, Zhang H, Berry GJ, Wallis BB, Schaefgen B, Harrison DG, Tremmel JA, Giacomini JC, Goronzy JJ, Weyand CM.
Watanabe R, et al. Among authors: berry gj.
J Clin Invest. 2017 Jun 30;127(7):2725-2738. doi: 10.1172/JCI92167. Epub 2017 Jun 12.
J Clin Invest. 2017.
PMID: 28604383
Free PMC article.